Phibro Animal Health (PAHC) Treasury Shares (2018 - 2026)
Phibro Animal Health's (PAHC) quarterly Treasury Shares came in at $650524.0 in Q1 2026, up 14.13% year-on-year from $570000.0 in Q1 2025, and down 4.64% quarter-over-quarter from $682162.0 in Q4 2025.
Phibro Animal Health (PAHC) Treasury Shares (2018 - 2026) Analysis & Trends
Phibro Animal Health's Treasury Shares history runs 5 years deep, the most recent figure standing at $650524.0 for Q1 2026.
- On a quarterly basis, Treasury Shares rose 14.13% year-over-year to $650524.0 in Q1 2026; TTM through Mar 2026 was $650524.0, a 14.13% increase from a year earlier, with the FY2025 full-year figure at $570000.0, changed N/A from the prior year.
- Treasury Shares fell to $650524.0 in Q1 2026 per PAHC's latest filing, from $682162.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $683847.0 in Q3 2025 and bottomed at $570000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 650,524.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 650,524.00 |
| Mar 31, 2026 | 650,524.00 |
| Dec 31, 2025 | 682,162.00 |
| Dec 31, 2025 | 682,162.00 |
| Sep 30, 2025 | 683,847.00 |
| Sep 30, 2025 | 683,847.00 |
| Jun 30, 2025 | 570,000.00 |
| Jun 30, 2025 | 570,000.00 |
| Mar 31, 2025 | 570,000.00 |
| Mar 31, 2025 | 570,000.00 |
| Jun 30, 2020 | 250,000.00 |
| Jun 30, 2020 | 250,000.00 |
| Jun 30, 2019 | 250,000.00 |
| Jun 30, 2019 | 250,000.00 |
| Jun 30, 2018 | 250,000.00 |
| Jun 30, 2018 | 250,000.00 |